本文選題：JQ　切入點：哮喘　出處：《中國當代兒科雜志》2017年12期 　論文類型：期刊論文

【摘要】：目的探討溴化結(jié)構(gòu)域蛋白抑制劑JQ1對哮喘小鼠氣道重塑治療的分子學機制。方法將24只小鼠隨機分成對照組、OVA誘導哮喘組(OVA組)、JQ1干預哮喘組(JQ1+OVA組)(n=8)。采用OVA致敏/激發(fā)制備哮喘小鼠模型,霧化激發(fā)前1h,JQ1+OVA組小鼠經(jīng)腹腔注射JQ1溶液(50μg/g)。末次激發(fā)24h后留取支氣管肺泡灌洗液(BALF)及肺組織,計算各組BALF中細胞總數(shù)及嗜酸性粒細胞百分比,肺組織行病理染色觀察各組小鼠肺組織病理改變;采用RT-PCR及Westernblot法分別檢測小鼠肺上皮間質(zhì)轉(zhuǎn)化(EMT)過程中鈣黏蛋白(E-Cadherin)、波形蛋白(vimentin)m RNA及蛋白水平的表達變化。結(jié)果與對照組比較,OVA組小鼠氣道炎性細胞明顯浸潤,氣道壁增厚,黏液滲出增多;BALF中細胞總數(shù)增加,嗜酸性粒細胞百分比增多(P0.01)。與OVA組比較,JQ1+OVA組小鼠氣道炎癥反應明顯減輕;BALF中細胞總數(shù)明顯減少,嗜酸性粒細胞百分比降低(P0.01)。與對照組比較,OVA組小鼠肺組織氣道上皮E-Cadherinm RNA及蛋白表達水平明顯下調(diào),vimentinm RNA及蛋白表達水平明顯上調(diào)(P0.01);與OVA組比較,JQ1+OVA組E-Cadherinm RNA及蛋白表達水平升高,vimentinm RNA及蛋白表達水平下降(P0.01);JQ1+OVA組與對照組上述指標表達水平比較差異無統(tǒng)計學意義(P0.05)。結(jié)論 OVA哮喘小鼠存在EMT氣道重塑;溴化結(jié)構(gòu)域蛋白抑制劑JQ1可降低哮喘小鼠氣道炎癥,抑制EMT,減輕氣道重塑,為哮喘治療提供了一個潛在的新方向。
[Abstract]:Objective to investigate the molecular mechanism of brominated domain protein inhibitor (JQ1) in the treatment of airway remodeling in asthmatic mice. Methods 24 mice were randomly divided into control group (OVA-induced asthma group) and JQ1 intervention group (JQ1 OVA group). OVA was used to sensitize the mice. / induced asthma mouse model, The mice in JQ1 OVA group were injected intraperitoneally with 50 渭 g / g JQ1 solution 1 hour before atomization. The bronchoalveolar lavage fluid (BALF) and lung tissue were collected 24 hours after the last stimulation. The total number of cells in BALF and the percentage of eosinophils in each group were calculated. The pathological changes of lung tissue in each group were observed by pathological staining. The expression of E-Cadherin, vimentin, vimentin RNA and protein during the process of lung epithelial interstitial transformation in mice were detected by RT-PCR and Westernblot. Results compared with the control group, the airway inflammatory cells infiltrated obviously and the airway wall became thicker in the OVA group. Compared with the OVA group, the airway inflammatory response in the JQ1 OVA group was significantly reduced, and the total number of the cells in the BALF was significantly decreased compared with that in the OVA group, while the percentage of eosinophils in the BALF was increased and the percentage of eosinophilic granulocytes in the BALF was increased. The percentage of eosinophilic granulocytes decreased (P 0.01). Compared with the control group, the expression of E-Cadherinm RNA and protein in the lung epithelium of the OVA group significantly decreased the expression level of vimentinm RNA and protein, and the expression of E-Cadherinm RNA and protein in the JQ1 OVA group was significantly up-regulated than that in the OVA group, and the expression of E-Cadherinm RNA and protein in JQ1 OVA group was significantly higher than that in the OVA group. There was no significant difference in the expression level of RNA and protein between the P0.01JQ1 OVA group and the control group. Conclusion there is EMT remodeling in the airway of OVA asthmatic mice. Brominated domain protein inhibitor (JQ1) can reduce airway inflammation, inhibit EMTs and reduce airway remodeling in asthmatic mice.
【作者單位】： 南昌大學醫(yī)學院;江西省人民醫(yī)院呼吸科;江西省人民醫(yī)院中心實驗室;江西省兒童醫(yī)院中心實驗室;
【基金】：江西省科技廳重大科研基金(20151BBB70267)
【分類號】：R-332;R562.25

【相似文獻】

相關(guān)期刊論文 前3條

1 錢振福;崔芳囡;;國內(nèi)支氣管哮喘氣道重塑動物模型的研究進展[J];醫(yī)學綜述;2009年01期

2 羅永峰;徐軍;;Th1炎癥在慢性塵螨暴露誘導的小鼠氣道重塑中的地位[J];中國病理生理雜志;2010年10期

3 杜強;張倩;沈立;蔡健康;黃茂;殷凱生;;黃芪甲苷對慢性哮喘模型小鼠氣道重塑的影響[J];中國藥理學通報;2011年10期

相關(guān)會議論文 前3條

1 李艷萍;;小鼠氣道重塑模型早期核因子κB通路中轉(zhuǎn)化生長因子β_1表達的研究[A];中華醫(yī)學會第七次全國呼吸病學術(shù)會議暨學習班論文匯編[C];2006年

2 吳壯;羅永峰;徐軍;;利用SMA-Cre/R26R轉(zhuǎn)基因報告鼠建立支氣管哮喘氣道重塑動物模型[A];中華醫(yī)學會第五次全國哮喘學術(shù)會議暨中國哮喘聯(lián)盟第一次大會論文匯編[C];2006年

3 陳宏釗;張永斌;;益氣化痰治法對COPD模型大鼠細胞因子和氣道重塑的干預作用研究[A];第十屆中國實驗動物科學年會論文集[C];2012年

相關(guān)碩士學位論文 前4條

1 張倫靜;孕期、哺乳期補充適量1,25-(OH)_2D_3對哮喘大鼠模型氣道重塑及肺組織中HMGB1、IL-1β的影響[D];南昌大學;2016年

2 王達;射干麻黃湯對支氣管哮喘模型小鼠氣道重塑及TGF-β_1、1L-17A表達的影響[D];黑龍江中醫(yī)藥大學;2017年

3 程雪兵;促紅細胞生成素對哮喘小鼠氣道重塑模型的影響[D];延邊大學;2017年

4 陶偉利;益氣補血活血法干預COPD氣道重塑大鼠模型的實驗研究[D];云南中醫(yī)學院;2015年

，

本文編號：1644061